Dchs1-Fat4 regulation of osteogenic differentiation in mouse

Crespo-Enriquez, I and Hodgson, T and Zakaria, S and Cadoni, E and Shah, M and Allen, S and Al-Krishali, A and Mao, Y and Yiu, A and Villagomez-Olea, G and Petzold, J and Pitsillides, A A and Irvine, K and Francis-West, P (2019) Dchs1-Fat4 regulation of osteogenic differentiation in mouse. DEVELOPMENT, 146.

[img] Text
12265_Dchs1-Fat4-regulation-of-osteogenic-differentiation-in-mouse.pdf - Published Version
Restricted to Repository staff only until 29 July 2020.
Available under License Creative Commons Attribution Non-commercial.

Download (14MB)

Abstract

In human, mutations of the protocadherins FAT4 and DCHS1 result in Van Maldergem syndrome, which is characterised, in part, by craniofacial abnormalities. Here, we analyse the role of Dchs1-Fat4 signalling during osteoblast differentiation in mouse. We show that Fat4 and Dchs1 mutants mimic the craniofacial phenotype of the human syndrome and that Dchs1-Fat4 signalling is essential for osteoblast differentiation. In Dchs1/Fat4 mutants, proliferation of osteoprogenitors is increased and osteoblast differentiation is delayed. We show that loss of Dchs1-Fat4 signalling is linked to increased Yap-Tead activity and that Yap is expressed and required for proliferation in osteoprogenitors. In contrast, Taz is expressed in more-committed Runx2-expressing osteoblasts, Taz does not regulate osteoblast proliferation and Taz-Tead activity is unaffected in Dchs1/Fat4 mutants. Finally, we show that Yap and Taz differentially regulate the transcriptional activity of Runx2, and that the activity of Yap-Runx2 and Taz-Runx2 complexes is altered in Dchs1/Fat4 mutant osteoblasts. In conclusion, these data identify Dchs1-Fat4 as a signalling pathway in osteoblast differentiation, reveal its crucial role within the early Runx2 progenitors, and identify distinct requirements for Yap and Taz during osteoblast differentiation.